China Health Technology Group Ltd. (1069)

Overview

China Bozza Development Holdings Limited is an integral enterprise focusing on sustainable growth within the forestry sector in the People's Republic of China. Initially established in 2009 under the name China Agroforestry Low-Carbon Holdings Limited, it underwent a name change in January 2020 to better reflect its evolving business strategy and commitment towards development. Headquartered in Shenzhen, China, the company prides itself on a diversified business model that includes forestry management and ginseng cultivation and trading. This dual approach allows it to leverage the ecological benefits of forestry while diversifying its income stream through the cultivation of high-value ginseng. Its operations are mainly divided into two segments: Forestry Business, which encompasses the plantation, logging, and sale of timber and related products, and Ginseng Business, focusing on ginseng plantation and trading activities. With an emphasis on sustainability and carbon reduction, China Bozza Development Holdings Limited seeks to contribute positively to the environment while achieving financial growth.

Products and Services

The core operations of China Bozza Development Holdings Limited are categorized into two main segments, reflecting the company's strategic focus areas:

• Forestry Business - This segment is at the heart of the company's operations, covering a broad spectrum of activities from the cultivation of forests to the logging and marketing of timber and timber-related products. The company employs sustainable forestry management practices to ensure the ecological balance is maintained, while simultaneously extracting economic value from this renewable resource. This segment not only contributes to the company's revenue but also aligns with global efforts for carbon footprint reduction through responsible forestry management.
• Ginseng Business - Serving as a diversification from its forestry operations, China Bozza Development Holdings Limited has also invested in the cultivation and trading of ginseng. This high-value crop known for its medicinal properties adds a significant dimension to the company's portfolio, leveraging agricultural expertise to tap into the lucrative market of traditional Chinese medicine and health supplements. The cultivation of ginseng is managed with utmost care to produce high-quality yields that meet the demands of both domestic and international markets.